Meaningful real-world data for Value and Access, HEOR
Volv Global provides data-driven understanding of disease endpoints and outcomes to support pricing and reimbursement calculations, regulatory and HTA submissions, payer evidence packages and comparative economics studies with real-world evidence.

Better understanding of disease
Analyse real-world treatment pathways and their effectiveness to define more precise endpoints for better analysis of disease progression and outcomes.
Generate evidence from credible RWD
Compare treatment effectiveness via analysis of real-world outcomes of different intervention.
Refine value proposition
Identify cohorts more precisely and at an early stage for better longitudinal assessment of patient health outcomes.
Quantify disease burden
Understand the real-world impact on quality of life and healthcare utilisation for payer evidence packages and comparative economic studies